BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Offer Details
Shares of common stock (or pre-funded warrants) offered by BioSig Technologies, Inc.
Use of Proceeds
Intends to use net proceeds to purchase gold bullion, for working capital, and general corporate purposes.
Offering Conditions
Subject to market conditions with no assurance regarding timing, size, or terms.
- BioSig aims to enhance its financial position through the public offering.
- The acquisition of gold bullion aligns with the company's investment policy and diversification strategy.
Investors are advised to review all related documents before participating in the offering to make informed decisions about BioSig's future.